{"schema_version":"secwatch.filing_event.v1","accession":"0000886163-26-000041","form_type":"8-K","ticker":"LGND","cik":"0000886163","company_name":"LIGAND PHARMACEUTICALS INC","filed_at":"2026-08-06T11:05:02+00:00","discovered_at":"2026-08-06T11:10:07.335831+00:00","generated_at":"2026-08-06T11:10:41.712851+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ligand Q2 royalty rev +32% YoY; raises 2026 adj EPS guidance; closes XOMA deal","bullets":["Q2 royalty rev $48.0M (+32% YoY); total rev $63.7M (+34%); GAAP EPS $2.22 (vs $0.24); adj EPS $2.37 (vs $1.60).","2026 adj EPS guidance raised to $9.00-$9.50 (from $8.50-$9.50); total revenue guidance unchanged at $270M-$310M.","Completed XOMA Royalty acquisition on July 14 for $39.00/share + CVR; expected to add ~$0.50 to 2026 adj EPS and ~$1.50 to 2027 adj EPS.","Issued $700M 0% convertible notes due 2031; repurchased 228,859 shares at ~$262/share using $60M of proceeds.","Cash & short-term investments $1.36B at June 30, up from $733.5M at Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000886163-26-000041","json":"https://secwatch.observer/filing/0000886163-26-000041.json","markdown":"https://secwatch.observer/filing/0000886163-26-000041.md","text":"https://secwatch.observer/filing/0000886163-26-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886163/000088616326000041/0000886163-26-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886163/000088616326000041/lgnd-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:10:41.712851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}